Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Inflammation and accelerated atherosclerosis: basic mechanisms.

Andrea Doria1, Yaniv Sherer, Pier L Meroni

  • 1Division of Rheumatology, Department of Medical and Surgical Science, University of Padua, Via Guistiniani 2, 35128 Padua, Italy.

Rheumatic Diseases Clinics of North America
|June 1, 2005
PubMed
Summary

Autoimmune rheumatic diseases accelerate atherosclerosis through immunologic-inflammatory pathways. Targeting these pathways could offer future treatments for atherosclerosis, a leading cause of death.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Do DMARDs increase the risk of cancer recurrence in patients with spondyloarthritis, psoriatic arthritis and rheumatoid arthritis?

Clinical and experimental rheumatology·2026
Same author

Comparative real-world effectiveness and safety of benralizumab and two mepolizumab dosing regimens in eosinophilic granulomatosis with polyangiitis: a 24-month prospective single-center cohort study.

Frontiers in immunology·2026
Same author

Novel mechanisms linking platelet activation to antiphospholipid syndrome.

Current opinion in immunology·2026
Same author

Switching from intravenous to subcutaneous infliximab in Behçet's disease: feasibility, safety and early outcomes.

Clinical and experimental rheumatology·2026
Same author

Advancing Care in Lupus Nephritis: Expert Perspectives on Current Practices and Future Directions in Italy.

Journal of clinical medicine·2026
Same author

Early belimumab accelerates renal response and reduces glucocorticoid exposure in lupus nephritis: a multicentre propensity-matched study.

Rheumatology (Oxford, England)·2026

Area of Science:

  • Immunology
  • Rheumatology
  • Cardiovascular Disease

Background:

  • Autoimmune rheumatic diseases share pathogenic mechanisms with accelerated atherosclerosis.
  • Immunologic-inflammatory processes are implicated in atherosclerosis development.
  • These inflammatory states are present in autoimmune diseases and the general population.

Purpose of the Study:

  • To summarize the role of autoimmune rheumatic diseases in atherosclerosis pathogenesis.
  • To highlight the immunologic-inflammatory mechanisms underlying atherosclerosis.
  • To explore potential immunomodulatory treatments for atherosclerosis.

Main Methods:

  • Literature review of studies on autoimmune diseases and atherosclerosis.
  • Analysis of immunologic-inflammatory mechanisms in disease pathogenesis.

Related Experiment Videos

  • Discussion of experimental immunomodulatory approaches.

    • Main Results:

    • Immunologic-inflammatory mechanisms are key risk factors for accelerated atherosclerosis.
    • Evidence supports a significant role for these mechanisms in atherosclerosis development.
    • The immunologic-inflammatory state is not limited to overt autoimmune diseases.

    Conclusions:

    • Autoimmune rheumatic diseases contribute to atherosclerosis via shared inflammatory pathways.
    • Future research should focus on immunomodulation for atherosclerosis treatment.
    • Targeting inflammation offers a promising therapeutic strategy for atherosclerosis.